71267-22-6O=NN1CC=CC[C@H]1c1cccnc1ZJOFAFWTOKDIFH-JTQLQIEISA-N3-[(2S)-1-nitroso-3,6-dihydro-2H-pyridin-2-yl]pyridine has been reported in Nicotiana tabacum with data available.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 7.1% (3 of 42) of reports.
Danger
H301 (92.9%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory.
N'-Nitrosoanatabine (NAT)
Group 3: Not classifiable as to its carcinogenicity to humans
Volume 37: (1985) Tobacco Habits Other than Smoking; Betel-quid and Areca-nut Chewing; and Some Related Nitrosamines
2007
2004
UsesThe S-enantiomer metabolite of tobacco, a specific N-nitrosamines with carcinogenic activity.
General DescriptionN-Nitrosoanatabine or NAT is a potent carcinogen and biomarker of exposure to cigarette smoke. It′s found in a variety of tobacco products such as cigarettes, electronic cigarettes, nicotine gum and oral snuff. This certified Snap-N-Spike solution is suitable for use in LC-MS/MS or GC/MS methods for nicotine testing, environmental monitoring, or clinical and diagnostic testing of nicotine biomarkers.
No reaction records under the current filter.
Loading…
71267-22-6DTXSID70221442